Can a Gold-Based drug revive brain cells in MS?
NCT ID NCT03993171
First seen Dec 24, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tested a drug called CNM-Au8 in 33 people with relapsing multiple sclerosis (MS). The goal was to see if it could improve energy levels in brain cells, which may help slow the disease. Participants took the drug for 12 weeks while researchers used special brain scans to measure changes. The study was completed and focused on safety and how the drug affects brain metabolism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Southwestern
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.